Lice Treatment Market, Trends, Absolute Opportunity and Value Chain 2019

Lice are parasites that feed on human blood. They are majorly found on the head and near the pubic areas. However, in certain cases, infestations of head lice are reported to occur by close contact with infected people or through pets. From the past few years, the prevalence of head lice has increased, resulting in a parallel demand for therapeutics. Lice Treatment market grows at 6.5% of CAGR which is segmented based on type, treatment, end user, and region.

An article published by the Centers for Disease Control and Prevention in 2015, stated that ~6 million to 12 million infestations occur each year within the U.S. Moreover, the article suggested that most of the reported cases were for children of 3 to 11 years of age. Since, this susceptible population is increasing within the U.S., the market is projected to grow within the region.

Browse Complete 90 Pages Premium Research Report Enabled with Tables and Figures @ https://www.marketresearchfuture.com/reports/lice-treatment-market-6934

According to the database of the U.S. Census Bureau, it was estimated that there were approximately 20,304,238 children who aged 5-9 years within the region. However, factors such as lack of awareness and low per capita healthcare expenditure in the developing and low-income countries is estimated to be major restriction for market growth during the forecast period, 2018-2023

Lice Treatment Market - Key Players

Some of the key players in the global lice treatment market are AkzoNobel N.V., Alliance Pharmaceuticals Ltd., Bayer HealthCare, Dow AgroSciences LLC, Elanco, GlaxoSmithKline, Insight Pharmaceuticals, Johnson & Johnson, Omega Pharma, Pfizer, Sanofi, Suven Life Sciences, Taro Pharmaceuticals, Topaz Pharmaceuticals Inc., and others

Lice Treatment Market - Segmentation

The Global Lice Treatment Market is segmented based on type, treatment, end user, and region

On the basis of type, the market is segmented into pediculosis capitis, pediculosis corporis, pediculosis pubis. Based on treatment, the market is devised into two, i.e., OTC (over the counter) products and prescription medications. The OTC medication segment is sub-segmented into permethrin, pyrethrin, others.

The prescription segment is sub-segmented into ivermectin, Spinosad, malathion, and others. By end user, the market is divided into hospitals & clinics, retail pharmacies, online platform. In the current scope of the study the above-mentioned segments are divided into four global regions, namely- the Americas, Europe, Asia Pacific and the Middle East & Africa.

For More Information Visit @ http://heraldkeeper.com/market/lice-treatment-market-witness-comprehensive-growth-2023-207745.html

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: salesteam@marketresearchfuture.com

Market Research Future with their unique quality of simplifying the market research study, announces a qualitative study report on Huntington’s Disease Treatment Market